Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Internal Medicine (Tokyo, Japan)|July 12, 2019
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with PolyangiitisTakahiro Yamada, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Scientific Reports|February 22, 2023
Preserved ratio impaired spirometry with or without restrictive spirometric abnormalityShinichiro Miura, Hiroshi Iwamoto, Keitaro Omori, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2025
HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLCKunihiko Funaishi, Kakuhiro Yamaguchi, Hiroki Tanahashi, et al.
Respiratory Medicine Case Reports|October 14, 2024
Primary pulmonary extranodal NK/T-cell lymphoma diagnosed by thoracoscopic lung biopsy: A case reportMichihiko Tanaka, Yasushi Horimasu, Kazuma Kawamoto, et al.
Molecular Therapy. Nucleic Acids|December 1, 2025
Systemic miR-26a deficiency attenuates pulmonary fibrosis via PTEN upregulation and downstream TIMP-1 suppressionArisa Hamada, Kiyofumi Shimoji, Taku Nakashima, et al.
BMJ Open Respiratory Research|February 20, 2024
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosisShinichiro Miura, Hiroshi Iwamoto, Masashi Namba, et al.
Respiratory Medicine|May 27, 2019
Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumoniaSachiko Shioya, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Medicine|February 20, 2021
A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept studyYasushi Horimasu, Shinichiro Ohshimo, Kakuhiro Yamaguchi, et al.
Pageof 12